G.D. Searle, LLC
G.D. Searle, LLC[edit | edit source]
G.D. Searle, LLC was an American pharmaceutical company, renowned for its innovations in the development and sale of medications and other products. Founded in Omaha, Nebraska, the company played a significant role in the pharmaceutical industry throughout much of the 20th century.
Overview[edit | edit source]
G.D. Searle was known not only for its pharmaceutical products but also for its role in advancements in health and nutrition. The company pioneered several drugs, gaining respect and recognition within the medical community.
History[edit | edit source]
- 1888: Gideon Daniel Searle founded the company in Omaha, Nebraska. Initially, it started as a drug sales firm, expanding into drug manufacturing by the early 1900s.
- 1940s-1950s: The company became known for its introduction of innovative products, including the first oral contraceptive, Enovid.
- 1985: Monsanto Company acquired G.D. Searle.
- 2000: Monsanto merged with Pharmacia & Upjohn, which eventually spun off its pharmaceutical business into a new company called Pharmacia.
- 2003: Pfizer acquired Pharmacia, and with it, the legacy of G.D. Searle's pharmaceutical portfolio.
Notable Products[edit | edit source]
- Enovid: Introduced in the 1950s, Enovid was the first oral contraceptive pill.
- Celebrex (celecoxib): A nonsteroidal anti-inflammatory drug (NSAID) developed for pain management.
- NutraSweet: A brand of aspartame, an artificial sweetener, that became a popular sugar substitute.
Research and Development[edit | edit source]
G.D. Searle was known for its commitment to research and development. Their dedication to innovation led to the discovery of several groundbreaking medications and therapies. Their R&D facilities were home to numerous scientists and researchers focused on diverse therapeutic areas.
Controversies[edit | edit source]
Like many pharmaceutical firms, G.D. Searle faced challenges, notably concerning the safety and approval processes of some of its products. The most well-known controversy surrounded the safety of aspartame, with debates over its health impacts.
Legacy[edit | edit source]
Though G.D. Searle no longer operates as a standalone company, its legacy persists. Many of its drugs are still widely prescribed, and the company's approach to pharmaceutical research continues to influence the industry.
See Also[edit | edit source]
References[edit | edit source]
- [1] "History of G.D. Searle". G.D. Searle Archives.
- [2] "Monsanto and G.D. Searle: A Merger History". Monsanto Historical Review.
- [3] "Pfizer and Pharmacia Merger". Pfizer Official Documents.
 | This corporation or company article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
